Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 138.45
-0.84 (-0.60%)
Feb 2, 2026, 3:29 PM IST
Suven Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 150.26 | 149.32 | 370.19 | 52.74 | 93.48 |
Short-Term Investments | - | 227.01 | 1,490 | 1,451 | - | 369.2 |
Trading Asset Securities | - | 222.79 | 759.35 | 463.39 | 451.62 | 0.86 |
Cash & Short-Term Investments | 2,575 | 600.05 | 2,399 | 2,284 | 504.36 | 463.54 |
Cash Growth | 54.67% | -74.98% | 5.01% | 352.91% | 8.80% | 214.79% |
Accounts Receivable | - | 13.36 | 12.86 | 8.07 | 12.98 | 17.62 |
Other Receivables | - | 0.76 | 22.02 | 47.67 | 75.25 | 62.79 |
Receivables | - | 14.12 | 34.88 | 55.74 | 88.23 | 494.89 |
Inventory | - | 2.38 | 7.08 | 0.08 | 0.33 | 5.01 |
Prepaid Expenses | - | 10.02 | 5.9 | 3.57 | 4.33 | 4.12 |
Other Current Assets | - | 128.16 | 120.19 | 172.19 | 68.7 | 59.25 |
Total Current Assets | - | 754.72 | 2,567 | 2,516 | 665.95 | 1,027 |
Property, Plant & Equipment | - | 594.82 | 280.1 | 370.16 | 408.91 | 256.01 |
Long-Term Investments | - | - | - | 1,000 | - | - |
Other Intangible Assets | - | 1.81 | 1.99 | 1.98 | 2.25 | 1.36 |
Other Long-Term Assets | - | 0.49 | 0.21 | 1.1 | 3.25 | - |
Total Assets | - | 1,352 | 2,849 | 3,889 | 1,080 | 1,284 |
Accounts Payable | - | 52.27 | 20.68 | 16.65 | 19.87 | 29.96 |
Accrued Expenses | - | 182.59 | 106.91 | 82.48 | 40.19 | 92.02 |
Current Portion of Long-Term Debt | - | - | - | - | 4.84 | 9.44 |
Current Portion of Leases | - | - | 7.1 | 10.26 | 11.51 | 11.01 |
Current Unearned Revenue | - | - | - | - | 0.56 | 1.06 |
Other Current Liabilities | - | - | 0.47 | 1.91 | 6.18 | 15.61 |
Total Current Liabilities | - | 234.86 | 135.16 | 111.3 | 83.15 | 159.1 |
Long-Term Debt | - | - | - | - | - | 3.93 |
Long-Term Leases | - | - | - | 5.79 | 15.73 | 23.26 |
Long-Term Unearned Revenue | - | - | - | - | - | 0.56 |
Pension & Post-Retirement Benefits | - | - | - | 3.77 | 7.97 | 10.36 |
Other Long-Term Liabilities | - | 17.11 | 13.46 | 15.05 | 12.05 | 6.93 |
Total Liabilities | - | 251.97 | 148.62 | 135.91 | 118.89 | 204.12 |
Common Stock | - | 218.07 | 218.07 | 218.07 | 145.38 | 127.28 |
Additional Paid-In Capital | - | 6,468 | 6,468 | 6,468 | 2,566 | 1,108 |
Retained Earnings | - | -5,573 | -3,965 | -2,914 | -1,733 | -511.47 |
Comprehensive Income & Other | - | -12.91 | -20.42 | -18.99 | -17.46 | 356.1 |
Shareholders' Equity | 2,813 | 1,100 | 2,700 | 3,753 | 961.45 | 1,080 |
Total Liabilities & Equity | - | 1,352 | 2,849 | 3,889 | 1,080 | 1,284 |
Total Debt | - | - | 7.1 | 16.05 | 32.09 | 47.64 |
Net Cash (Debt) | 2,575 | 600.05 | 2,392 | 2,268 | 472.27 | 415.9 |
Net Cash Growth | 54.90% | -74.91% | 5.44% | 380.28% | 13.55% | 377.36% |
Net Cash Per Share | 11.57 | 2.75 | 10.97 | 12.72 | 3.50 | 3.27 |
Filing Date Shares Outstanding | 224 | 218.07 | 218.07 | 218.07 | 145.38 | 127.28 |
Total Common Shares Outstanding | 224 | 218.07 | 218.07 | 218.07 | 145.38 | 127.28 |
Working Capital | - | 519.86 | 2,432 | 2,405 | 582.8 | 867.72 |
Book Value Per Share | 12.66 | 5.04 | 12.38 | 17.21 | 6.61 | 8.49 |
Tangible Book Value | 2,811 | 1,098 | 2,698 | 3,751 | 959.21 | 1,079 |
Tangible Book Value Per Share | 12.65 | 5.04 | 12.37 | 17.20 | 6.60 | 8.47 |
Land | - | 329.29 | 3.18 | 3.18 | 3.18 | 3.18 |
Machinery | - | 794.82 | 764.27 | 860.18 | 797.35 | 633.99 |
Construction In Progress | - | 0.1 | - | - | 35.51 | 47.74 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.